[The German program for disease management guidelines: type 2 diabetes--diabetic retinopathy/maculopathy guideline 2006. Short review].
In Germany, the first national consensus between six medical scientific associations on evidence-based recommendations for prevention and therapy of retinopathy/maculopathy in type 2 diabetes was reached in fall 2006. The recommendations' main sources are the NICE Retinopathy Guideline 2002, and existing German guidelines and reviews of recent scientific evidence. The article gives an overview on authors, sources, and key recommendations of the German National Disease Management Guideline Type 2 Diabetes-Retinopathy/Maculopathy 2006 (www.diabetes.versorgungsleitlinien.de).
Ollenschläger
Günter
G
Arztliches Zentrum für Qualität in der Medizin (AZQ), gemeinsames Institut von Bundesärztekammer und Kassenärztlicher Bundesvereinigung, Berlin, Germany. ollenschlaeger@azq.de
Kopp
Ina
I
Thole
Henning
H
Lelgemann
Monika
M
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001766:Blindness / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D003930:Diabetic Retinopathy / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D019468:Disease Management; D018450:Disease Progression; D042241:Early Diagnosis; D015444:Exercise; D005194:Family Practice; D005858:Germany; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007388:Internal Medicine; D008019:Life Style; D008268:Macular Degeneration / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D008875:Middle Aged; D009885:Ophthalmology; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012307:Risk Factors; D012955:Societies, Medical; D013997:Time Factors; D015431:Weight Loss
D006442:Glycated Hemoglobin